Mechanism of parathyroid tumourigenesis in uraemia

被引:31
作者
Tominaga, Y [1 ]
机构
[1] Nagoya 2nd Red Cross Hosp, Dept TRansplant Surg, Showa Ku, Nagoya, Aichi 466, Japan
关键词
D O I
10.1093/ndt/14.suppl_1.63
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Clonal analysis has shown that in renal hyperparathyroidism (2-HPT), parathyroid glands initially grow diffusely and polyclonally after which the foci of nodular hyperplasia are transformed to monoclonal neoplasia. There is a great deal of information about genetic abnormalities contributing to the tumourigenesis of parathyroid neoplasia in primary hyperparathyroidism. It is speculated that allelic loss of the MEN1 suppressor gene and overexpression of cyclin D1 induced by rearrangement of the parathyroid hormone gene may be the major genetic abnormality in sporadic parathyroid adenoma but not in 2-HPT. The pathogenesis of 2-HPT, abnormality of the Ca2+-sensing receptor (CaR) gene and the vitamin D receptor gene may possibly contribute to parathyroid tumourigenesis in 2-HPT. However, this is not yet clear and heterogeneous and multiple genetic abnormalities may be responsible for the progression of secondary parathyroid hyperplasia.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 12 条
[1]   MOLECULAR-CLONING AND CHROMOSOMAL MAPPING OF DNA REARRANGED WITH THE PARATHYROID-HORMONE GENE IN A PARATHYROID ADENOMA [J].
ARNOLD, A ;
KIM, HG ;
GAZ, RD ;
EDDY, RL ;
FUKUSHIMA, Y ;
BYERS, MG ;
SHOWS, TB ;
KRONENBERG, HM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :2034-2040
[2]   Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].
Chandrasekharappa, SC ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Collins, FS ;
EmmertBuck, MR ;
Debelenko, LV ;
Zhuang, ZP ;
Lubensky, IA ;
Liotta, LA ;
Crabtree, JS ;
Wang, YP ;
Roe, BA ;
Weisemann, J ;
Boguski, MS ;
Agarwal, SK ;
Kester, MB ;
Kim, YS ;
Heppner, C ;
Dong, QH ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
SCIENCE, 1997, 276 (5311) :404-407
[3]   LOSS OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE IN PARATHYROID CARCINOMA [J].
CRYNS, VL ;
THOR, A ;
XU, HJ ;
HU, SX ;
WIERMAN, ME ;
VICKERY, AL ;
BENEDICT, WF ;
ARNOLD, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (11) :757-761
[4]   PROGRESSION OF UREMIC HYPERPARATHYROIDISM INVOLVES ALLELIC LOSS ON CHROMOSOME-11 [J].
FALCHETTI, A ;
BALE, AE ;
AMOROSI, A ;
BORDI, C ;
CICCHI, P ;
BANDINI, S ;
MARX, SJ ;
BRANDI, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :139-144
[5]   Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism [J].
Farnebo, F ;
Teh, BT ;
Dotzenrath, C ;
Wassif, WS ;
Svensson, A ;
White, I ;
Betz, R ;
Goretzki, P ;
Sandelin, K ;
Farnebo, LO ;
Larsson, C .
HUMAN GENETICS, 1997, 99 (03) :342-349
[6]   Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism [J].
Gogusev, J ;
Duchambon, P ;
Hory, B ;
Giovannini, M ;
Goureau, Y ;
Sarfati, E ;
Drueke, TB .
KIDNEY INTERNATIONAL, 1997, 51 (01) :328-336
[7]   Cyclin D1/PRAD1 expression in parathyroid adenomas: An immunohistochemical study [J].
Hsi, ED ;
Zukerberg, LR ;
Yang, WI ;
Arnold, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1736-1739
[8]  
Tahara H, 1996, CANCER RES, V56, P599
[9]  
Tominaga Y, 1997, SEMIN SURG ONCOL, V13, P78, DOI 10.1002/(SICI)1098-2388(199703/04)13:2<78::AID-SSU3>3.3.CO
[10]  
2-M